Pre-earnings options volume in Iovance Biotherapeutics (IOVA) is 1.2x normal with calls leading puts 4:3. Implied volatility suggests the market is anticipating a move near 23.8%, or 62c, after results are released. Median move over the past eight quarters is 16.0%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer
- Unusually active option classes on open July 23rd
- Iovance Biotherapeutics Gains Competitive Edge as Replimune Faces FDA Setback
- Realty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
- Iovance Biotherapeutics Appoints New Chief Financial Officer